找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Optimal Use of Sandimmun in Endogenous Uveitis; D. BenEzra,R. B. Nussenblatt,P. Timonen Conference proceedings 1988Latest edition Sandoz L

[復(fù)制鏈接]
查看: 44231|回復(fù): 40
樓主
發(fā)表于 2025-3-21 18:34:19 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Optimal Use of Sandimmun in Endogenous Uveitis
編輯D. BenEzra,R. B. Nussenblatt,P. Timonen
視頻videohttp://file.papertrans.cn/703/702948/702948.mp4
圖書封面Titlebook: Optimal Use of Sandimmun in Endogenous Uveitis;  D. BenEzra,R. B. Nussenblatt,P. Timonen Conference proceedings 1988Latest edition Sandoz L
描述Due to the largely disappointing therapeutic and sight- Ensuing from the above observations, the following guidelines are suggested: saving results achieved so far with conventional therapy using systemic corticosteroids and cytotoxic agents, new treatment modalities have been sought. a) Start treatment with Sandimmun at initial doses of During the last four years, a total of over 300 patients 5 mg/kg/day. b) Use Sandimmun in combination with low dose sys- suffering from endogenous intermediate and posterior temic corticosteroids if necessary, in order to uveitis, including more than 150 with Beh~et‘s disease achieve remission. involving the posterior segment of the eye, were treated with Sandimmun. The initial dose ranged from 5 to c) Use Sandimmun doses higher than 5 mg/kg/day on- 10 mg/kg/day. These patients were treated openly with ly when absolutely indicated. Sandimmun in 11 independent studies all over the d) Taper Sandimmun dose as rapidly as possible to a world (over 200 patients) and in a masked manner in 4 maintenance dose below 5 mg/kg/day. e) Do not discontinue treatment with Sandimmun rap- independent controlled studies (over 100 patients re- idly.
出版日期Conference proceedings 1988Latest edition
關(guān)鍵詞management; pathophysiology; physiology; safety; treatment; uveitis
版次1
doihttps://doi.org/10.1007/978-3-642-83368-7
isbn_ebook978-3-642-83368-7
copyrightSandoz Ltd, Basle / Springer-Verlag, Berlin Heidelberg 1988
The information of publication is updating

書目名稱Optimal Use of Sandimmun in Endogenous Uveitis影響因子(影響力)




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis影響因子(影響力)學(xué)科排名




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis網(wǎng)絡(luò)公開度




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis被引頻次




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis被引頻次學(xué)科排名




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis年度引用




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis年度引用學(xué)科排名




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis讀者反饋




書目名稱Optimal Use of Sandimmun in Endogenous Uveitis讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:08:02 | 只看該作者
Treatment of Endogenous Uveitis,nisolone 1.0%, fluometholone 0.1%) 4 to 10 times daily. Corticosteroid eye ointment at night time is added according to the severity of the ocular reaction. If constriction of the pupil with the formation of posterior synechiae is observed, strong short-acting mydriatics — cycloplegics (scopolamine
板凳
發(fā)表于 2025-3-22 01:01:02 | 只看該作者
Present Experience with Sandimmun,d posterior uveitis. In 11 studies from Europe, the U.S., Japan, Africa and Asia, over 200 patients suffering from endogenous uveitis refractory to treatment with steroids and cytotoxic drugs have been treated openly with Sandimmun. In 4 controlled masked studies from Israel, Japan, the U.S. and the
地板
發(fā)表于 2025-3-22 04:38:09 | 只看該作者
5#
發(fā)表于 2025-3-22 12:44:57 | 只看該作者
Patient Selection for Sandimmun Treatment,From the accumulating experience with the use of Sandimmun, the following two groups of patients are appropriate candidates for treatment:
6#
發(fā)表于 2025-3-22 14:24:29 | 只看該作者
7#
發(fā)表于 2025-3-22 20:25:15 | 只看該作者
8#
發(fā)表于 2025-3-22 21:13:56 | 只看該作者
References,Due to the largely disappointing therapeutic and sightsaving results achieved so far with conventional therapy using systemic corticosteroids and cytotoxic agents, new treatment modalities have been sought.
9#
發(fā)表于 2025-3-23 04:30:30 | 只看該作者
http://image.papertrans.cn/o/image/702948.jpg
10#
發(fā)表于 2025-3-23 09:23:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 14:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
蒙自县| 商河县| 弥勒县| 车险| 甘南县| 彰化市| 遵义市| 兴仁县| 滁州市| 南江县| 共和县| 延吉市| 巧家县| 甘南县| 牙克石市| 萍乡市| 定日县| 东城区| 黄陵县| 舟曲县| 保定市| 鄂伦春自治旗| 溆浦县| 西吉县| 称多县| 安乡县| 云霄县| 方山县| 湘西| 浪卡子县| 盘锦市| 涪陵区| 永定县| 昭苏县| 依安县| 封开县| 余庆县| 镶黄旗| 马鞍山市| 蒲江县| 乌苏市|